Cost-Effectiveness Analysis of Treatments to Reduce Cholesterol Levels, Blood Pressure and Smoking for the Prevention of Coronary Heart Disease

This publication has 28 references indexed in Scilit:

• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
  The Lancet, 1994
• On the decision rules of cost-effectiveness analysis
  Journal of Health Economics, 1993
• The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)
  Archives of internal medicine (1960), 1993
• Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: is individual intervention worth while?
  BMJ, 1991
• Principles of Cost-Effective Resource Allocation in Health Care organizations
  International Journal of Technology Assessment in Health Care, 1990
• Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia
  JAMA, 1988
• Primary prevention and coronary heart disease: the economic benefits of lowering serum cholesterol.
  American Journal of Public Health, 1986
• Cost-Effectiveness of Interventions to Prevent or Treat Coronary Heart Disease
  Annual Review of Public Health, 1985
• Allocation of Resources to Manage Hypertension
  New England Journal of Medicine, 1977